[On the treatment of Parkinson's syndrome with monoamine oxidase inhibitors alone and in combination with L-dopa].
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D008996:Monoamine Oxidase Inhibitors; D004295:Dihydroxyphenylalanine
Uber die Behandlung des Parkinsonsyndroms mit Monoaminoxydasehemmern allein und in Kombination mit L-Dopa.